• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T1a期前列腺癌的管理

Management of stage T1a prostate cancer.

作者信息

Lowe B A

机构信息

Division of Urology, Oregon Health Sciences University, Portland 97201, USA.

出版信息

Semin Urol Oncol. 1996 Aug;14(3):178-82.

PMID:8865481
Abstract

The patient with incidentally discovered prostate cancer by transurethral resection of the prostate (TURP) presents a difficult management problem for the clinician. These tumors are small and generally of low biologic potential. Offering aggressive treatment is not necessary in most patients; though in some patients, the tumor is not organ confined. Selecting that patient who may require tumor eradication to optimize survival requires careful analysis of known histological parameters identified at the time of diagnosis, an estimation of projected individual survival, and extensive counseling regarding options.

摘要

经尿道前列腺电切术(TURP)偶然发现前列腺癌的患者给临床医生带来了棘手的管理难题。这些肿瘤较小,通常生物学潜能较低。对大多数患者而言,无需采取积极治疗;不过,部分患者的肿瘤并非局限于器官内。要挑选出可能需要根除肿瘤以优化生存的患者,需要仔细分析诊断时确定的已知组织学参数,预估个体预期生存情况,并就各种选择进行充分的咨询。

相似文献

1
Management of stage T1a prostate cancer.T1a期前列腺癌的管理
Semin Urol Oncol. 1996 Aug;14(3):178-82.
2
Staging of incidentally detected prostate cancer: role of repeat resection, prostate-specific antigen, needle biopsy, and imaging.偶然发现的前列腺癌的分期:再次切除、前列腺特异性抗原、穿刺活检及影像学检查的作用
Semin Urol Oncol. 1996 Aug;14(3):156-64.
3
Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.前列腺特异性抗原(PSA)时代临床分期为T1a期前列腺癌患者病情进展的预测因素。
Eur Urol. 2008 Feb;53(2):355-61. doi: 10.1016/j.eururo.2007.06.020. Epub 2007 Jun 26.
4
Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.临床分期T1前列腺癌的亚分类:对根治性前列腺切除术后生化复发的影响。
J Urol. 2007 Oct;178(4 Pt 1):1277-80; discussion 1280-1. doi: 10.1016/j.juro.2007.05.153. Epub 2007 Aug 14.
5
Editorial comment on: predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.
Eur Urol. 2008 Feb;53(2):361. doi: 10.1016/j.eururo.2007.06.021. Epub 2007 Nov 28.
6
Editorial comment on: predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era.关于《PSA时代临床分期为T1a前列腺癌患者病情进展的预测因素》的编辑评论
Eur Urol. 2008 Feb;53(2):362. doi: 10.1016/j.eururo.2007.06.022. Epub 2007 Nov 28.
7
Can insignificant prostate cancer be predicted preoperatively in men with stage T1 disease?对于T1期疾病的男性患者,术前能否预测出无显著意义的前列腺癌?
Semin Urol Oncol. 1996 Aug;14(3):165-73.
8
Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.组织前列腺特异性抗原在内分泌治疗的前列腺癌中的预后意义。
Clin Cancer Res. 2000 Jan;6(1):160-5.
9
[Cancer of the prostate stage T1. Incidental carcinoma. Review of the literature and an appraisal of the classification].
Ann Urol (Paris). 1994;28(4):229-34.
10
Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.在前列腺特异性抗原(PSA)时代,经尿道前列腺切除术(TURP)期间发现T1a和T1b期(偶发性)前列腺癌的概率有所下降。
Prostate Cancer Prostatic Dis. 2009;12(1):57-60. doi: 10.1038/pcan.2008.14. Epub 2008 Apr 1.